Your browser is no longer supported. Please, upgrade your browser.
PLSE Pulse Biosciences, Inc. daily Stock Chart
Pulse Biosciences, Inc.
Index- P/E- EPS (ttm)-0.78 Insider Own18.70% Shs Outstand12.06M Perf Week28.63%
Market Cap394.48M Forward P/E- EPS next Y- Insider Trans14.06% Shs Float7.03M Perf Month143.38%
Income-9.50M PEG- EPS next Q- Inst Own1.50% Short Float2.48% Perf Quarter436.23%
Sales- P/S- EPS this Y-286.40% Inst Trans-14.63% Short Ratio0.81 Perf Half Y417.56%
Book/sh1.90 P/B17.22 EPS next Y- ROA-38.40% Target Price- Perf Year-
Cash/sh1.36 P/C24.05 EPS next 5Y- ROE-39.70% 52W Range4.03 - 35.93 Perf YTD403.23%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-17.14% Beta-
Dividend %- Quick Ratio16.40 Sales past 5Y- Gross Margin- 52W Low638.71% ATR2.47
Employees11 Current Ratio16.40 Sales Q/Q- Oper. Margin- RSI (14)72.43 Volatility11.76% 11.58%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume2.11 Prev Close32.71
ShortableYes LT Debt/Eq0.00 EarningsMar 14 Payout- Avg Volume215.67K Price29.77
Recom- SMA2031.83% SMA50103.04% SMA200283.94% Volume202,213 Change-8.99%
Mar-27-17 09:30AM  Xenon Pharmaceuticals Falls as Acne Drug Fails Study, Pulse Biosciences Submits 510(k) to FDA Accesswire +9.82%
Mar-26-17 10:25AM  Insider Buying Jumps as Market Volatility Grows: Sears, IFF, Pulse Biosciences, PRA Group, Radius Health and More
Mar-24-17 01:04PM  PULSE BIOSCIENCES, INC. Financials +17.19%
Mar-23-17 01:08PM  Insiders Load Up on Pulse Biosciences
Mar-20-17 05:17PM  PULSE BIOSCIENCES, INC. Files SEC form 10-K, Annual Report -5.96%
Mar-14-17 04:30PM  Pulse Biosciences Inc Earnings Call scheduled for 4:30 pm ET today
04:20PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:00PM  Pulse Biosciences Quartery Investor Conference Call Business Wire
08:30AM  Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System Business Wire
07:07AM  Q4 2016 Pulse Biosciences Inc Earnings Release - Time Not Supplied
Mar-01-17 04:46PM  Pulse Biosciences to Host Investor Conference Call on March 14, 2017 Business Wire
Feb-23-17 01:11PM  StreetSweeper's New Short: Pulse Biosciences
Feb-22-17 05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars at
Feb-21-17 05:13PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-10-17 09:24AM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S +23.84%
08:30AM  Pulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company Business Wire
Jan-27-17 03:53PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-14-16 04:01PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:00PM  Pulse Biosciences Quarterly Nano-Pulse Stimulation (NPS) Update Business Wire
08:00AM  Pulse Biosciences Announces First Clinical Use of the Proprietary PulseTx Platform in a Pilot Study in Dermatology Business Wire
Nov-11-16 08:00AM  Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits of Nano-Pulse Stimulation Technology Business Wire
Nov-02-16 03:00PM  Pulse Biosciences to Host Third Quarter Investor Conference Call on November 14, 2016 Business Wire
Oct-18-16 08:00AM  Pulse Biosciences to Present New Data at the Society for Immunotherapy in Cancer Annual Meeting Business Wire
Pulse Biosciences, Inc., a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is based in Burlingame, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zanganeh MakyDirectorMar 20Buy22.974,28098,30546,714Mar 20 09:48 PM
Zanganeh MakyDirectorMar 20Buy22.475,000112,360263,935Mar 20 09:48 PM
DUGGAN ROBERT W10% OwnerMar 18Buy23.01105,4862,427,1272,378,486Mar 20 09:50 PM
DUGGAN ROBERT W10% OwnerMar 17Buy24.0725,859622,4522,273,000Mar 20 09:50 PM
Zanganeh MakyDirectorMar 17Buy24.008,960215,00442,434Mar 20 09:48 PM
DUGGAN ROBERT W10% OwnerMar 16Buy24.1673,7821,782,3522,247,141Mar 20 09:50 PM
Zanganeh MakyDirectorFeb 15Buy11.9713,000155,64933,474Feb 22 02:48 PM
DUGGAN ROBERT W10% OwnerFeb 09Buy11.6441,624484,5032,173,359Feb 22 02:48 PM